Raju G, Walji M, Nemirovsky D, Devlin S, et al. Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease. Bone Marrow Transplant 2025 Oct 4. doi: 10.1038/s41409-025-02721.
PMID: 41046308